COVID-19 search strategies in PharmaPendium: Focus on drug safety and efficacy
About this talk
Many already approved drugs are currently being tested (repurposed) for prevention and treatment of COVID-19 infections and symptoms. To maximize repurposing and treatment success, you need to be fully informed on all regulatory DMPK, efficacy and drug safety data available on EMA and FDA approved drugs.
Elsevier’s PharmaPendium provides access to full text searchable FDA/EMA drug approval Documents, manually extracted data, expert taxonomies and prediction tools. Thereby it is ideally positioned to support COVID-19 repurposing and treatments efforts.
In this webinar PharmaPendium product manager Thomas Vargues and senior marketing manager drug safety Marnix Wieffer will show various PharmaPendium search strategies that are currently being used by pharmaceutical and healthcare customers. For this webinar they will focus on drug safety and efficacy workflows. For example:
1.What adverse effects can I expect when dosing above approved therapeutic dose?
2.What medication could aggravate COVID-19 disease symptoms and should be avoided?
3.What approved drugs have been tested against COVID-19 related indications, endpoints, symptoms or targets?
Getting answers to these critical questions can support drug repurposing efforts and reduce risk for patients.